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Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month
(MMM) is a global initiative aimed at raising awareness of high BP and to act as a temporary solution to the lack of screening pro-
grammes worldwide. A recently conducted study on 1.3 million adults in India showed the prevalence of hypertension to be 25.3%.
Raised BP is responsible for 8.5% of the total Disability Adjusted Life Years and is also an important contributor to cardiovascular dis-
ease which is the leading cause of deaths in the country. An opportunistic cross-sectional survey of volunteers aged 18 was carried
out in May 2017. Blood pressure measurement, the deﬁnition of hypertension and statistical analysis followed the standard MMM pro-
tocol. The study was conducted in over 500 screening sites across the country and involved over 5000 volunteers. Screening sites in-
cluded health facilities such as hospitals and clinics, as well as a variety of public spaces. A total of 240376 individuals were
screened during MMM17. Out of the 122685 screenees for whom all three BP readings were available, 38974 (31.8%) had hyperten-
sion based on the mean of second and third reading. Of individuals not receiving antihypertensive medication, 21679 (17.7%) were
hypertensive. Of individuals receiving antihypertensive medication, 14203 (82.6%) had uncontrolled BP. MMM17 was the largest col-
laborative BP screening campaign undertaken in India with involvement of the public as well as the private sector. Over two-thirds
of the individuals on antihypertensive treatment had uncontrolled BP. Approximately one-ﬁfth of the participants had raised BP and
were not on antihypertensive treatment prior to the study. These results suggest that opportunistic screening can identify signiﬁcant
numbers with raised BP.
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Introduction
Raised blood pressure (BP) is an important and growing
problem in India. According to a recent study of a nation-
ally representative sample of 1.3 million adults in India,
the crude prevalence of hypertension was found to be
25.3%.1 A recent study by the Global Burden of Disease
(GBD) study group shows that raised systolic BP is the fourth
leading risk factor for Disability Adjusted Life Years (DALYs)
in India and is responsible for 8.5% of the total DALY’s.2 As a
contributing risk factor for cardiovascular disease and
strokes, hypertension exerts considerable burden on the
country’s health system as well as on the national economy.
It is estimated that 28% of mortality in India is due to car-
diovascular disease,making it the leading cause of deaths.2
It is estimated that 16% of ischaemic heart disease, 21% of
peripheral vascular disease, 24% of acute myocardial
infarctions, and 29% of strokes are attributed to hyperten-
sion in India.3 High prevalence, coupled with low aware-
ness and treatment levels, leads to high levels of
uncontrolled BP in the community. Raising awareness re-
garding BP and improving detection rates through mass
screening is an important and vital step in fighting this
growing epidemic. The ‘May Measurement Month’ (MMM)
campaign of the International Society of Hypertension is an
initiative in this direction and leading organizations in the
country took part in order to raise awareness regarding the
silent killer.
Methods
The study in India was conducted by multiple study coordi-
nators considering its magnitude and widespread nature.
Multiple groups were involved in the survey conducted in
different regions of the country. The campaign was con-
ducted in over 500 screening sites across India. Screening
sites included hospitals, clinics, metro stations, residential
colonies, villages, diagnostic laboratories, and offices.
Institutional ethical clearance was taken from the respec-
tive Institutional Ethical Committees by all screening sites
involved in the study.
Over 5000 volunteers and investigators were involved in
the study. Volunteers were trained in BP measurement
technique by site coordinators at the various screening
sites. The study was conducted over a period of 31days in
the month of May 2017. Screenees were recruited using the
distribution of pamphlets, advertisements in online and
print media, and advocacy on social media. BP was mea-
sured by both automated as well as manual
sphygmomanometers.
All measurements were taken in a seated position.
Investigators and volunteers were asked to take three
measurements for each screenee. Self-estimated weight
and height were documented at most screening sites.
The Public Health Foundation of India created a web and
mobile application for data collection and was enabled for
offline capture of data. Data was cleaned and analysed lo-
cally by statisticians at the Public Health Foundation of
India.
Results
Data from 240 376 participants were cleaned, collated,
and analysed. All the study participants were of South
Asian ethnicity and the mean age was 39.5 years (SD 6
15; n¼ 139 282). More men (n¼ 129 109; 53.7%) than
women took part in the study. Out of the 122 685 screen-
ees for whom all three BP readings were available,
38 974 (31.8%) had hypertension based on the mean of
second and third reading or on history of anti-hyperten-
sive medication. A total of 17 205 (14.0%, n¼ 122 685)
participants were on anti-hypertensive treatment.
Excluding participants taking antihypertensive medica-
tion, 21 769 (20.6%, n¼ 105 480) participants with hyper-
tension were not receiving treatment. Among 17 205
participants who were receiving treatment for hyperten-
sion, 14 203 (82.6%) had uncontrolled BP. On analysis
after exclusion of individuals who had history of antihy-
pertensive treatment, there was no significant differ-
ence in mean systolic and diastolic BP between age
groups and gender using linear mixed model. Figure 1
shows significantly higher systolic and diastolic BP in
people receiving antihypertensive drug after adjustment
for age and sex. There is a significant increase in both
systolic and diastolic BP with an increasing body mass in-
dex (Figure 2).
Discussion
The MMM study in India was conducted withminimal prepa-
ration andmostly volunteer contributions. In a short period
of 4 months, collaborations were forged, ethical clearan-
ces taken and screening sites set up. Despite the limita-
tions, the study was able to screen almost a quarter of a
million individuals. The study has set an example for future
mass screening programmes in the country and is particu-
larly relevant considering the recent Government of India
initiative to conduct universal screening for diabetes, hy-
pertension, and three common cancers (oral, breast, and
cervical cancer).
Approximately one-third of our study participants were
found to have hypertension (140/90mmHg or on treat-
ment for raised BP). Although the study was conducted us-
ing convenience sampling and it is inappropriate to
compare with the true population prevalence, it is hard to
ignore the similarity between the proportion of hyperten-
sives in the study and the prevalence of hypertension in the
nationally representative sample.1
Close to one-fifth of the participants had hypertension
and were not on antihypertensive treatment prior to the
study. It is also alarming that less than a fifth of those on
antihypertensive treatment had their BP under control.
Similar findings of low awareness level and poor control of
BP among hypertensives has been reported by several stud-
ies in the past.4
Considering the high burden of hypertension and the
low level of awareness among the general population,
efforts such as MMM play a vital role in raising awareness,
initiating preventive measures in the normal at-risk
population, identifying hidden cases, and initiating
D60 A.P. Jose et al.
non-pharmacological as well as pharmacological inter-
ventions in those with overt hypertension. In addition to
the benefits at the population level, the campaign also
plays an important role in improving the levels of oppor-
tunistic screening among physicians. Large nationwide
studies such as the MMM are also vital in establishing net-
works between key players in the field of hypertension
and lays the foundation for concerted efforts in the
future.
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